These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 17401268)
41. Benign recurrent intrahepatic cholestasis: late initial diagnosis in adulthood. Ermis F; Oncu K; Ozel M; Yazgan Y; Gurbuz AK; Demirturk L; Demirci H; Akyol T; Hahoglu A Ann Hepatol; 2010; 9(2):207-10. PubMed ID: 20526019 [TBL] [Abstract][Full Text] [Related]
42. [Management of pruritus in patients with cholestatic liver disease]. Kremer AE; Kraus MR MMW Fortschr Med; 2016 Jun; 158(12):64-7. PubMed ID: 27324009 [No Abstract] [Full Text] [Related]
43. Review article: pruritus in cholestatic and other liver diseases. Mela M; Mancuso A; Burroughs AK Aliment Pharmacol Ther; 2003 Apr; 17(7):857-70. PubMed ID: 12656688 [TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study. Gonzales E; Hardikar W; Stormon M; Baker A; Hierro L; Gliwicz D; Lacaille F; Lachaux A; Sturm E; Setchell KDR; Kennedy C; Dorenbaum A; Steinmetz J; Desai NK; Wardle AJ; Garner W; Vig P; Jaecklin T; Sokal EM; Jacquemin E Lancet; 2021 Oct; 398(10311):1581-1592. PubMed ID: 34755627 [TBL] [Abstract][Full Text] [Related]
45. Advances in pathogenesis and management of pruritus in cholestasis. Kremer AE; Bolier R; van Dijk R; Oude Elferink RP; Beuers U Dig Dis; 2014; 32(5):637-45. PubMed ID: 25034299 [TBL] [Abstract][Full Text] [Related]
46. Benign recurrent intrahepatic cholestasis: improvement of pruritus and shortening of the symptomatic phase with rifampin therapy: a case report. Balsells F; Wyllie R; Steffen R; Kay M Clin Pediatr (Phila); 1997 Aug; 36(8):483-5. PubMed ID: 9272324 [No Abstract] [Full Text] [Related]
47. Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease. Neff GW; O'Brien CB; Reddy KR; Bergasa NV; Regev A; Molina E; Amaro R; Rodriguez MJ; Chase V; Jeffers L; Schiff E Am J Gastroenterol; 2002 Aug; 97(8):2117-9. PubMed ID: 12190187 [TBL] [Abstract][Full Text] [Related]
49. Itch and liver: management in primary care. Hegade VS; Kendrick SF; Rehman J; Jones DE Br J Gen Pract; 2015 Jun; 65(635):e418-20. PubMed ID: 26009537 [No Abstract] [Full Text] [Related]
50. Molecular Adsorbents Recirculating System dialysis in children with cholestatic pruritus. Schaefer B; Schaefer F; Wittmer D; Engelmann G; Wenning D; Schmitt CP Pediatr Nephrol; 2012 May; 27(5):829-34. PubMed ID: 22083365 [TBL] [Abstract][Full Text] [Related]
51. Evolving concepts of the pathogenesis and treatment of the pruritus of cholestasis. Jones EA; Bergasa NV Can J Gastroenterol; 2000 Jan; 14(1):33-40. PubMed ID: 10655025 [TBL] [Abstract][Full Text] [Related]
52. Improvement of cholestatic pruritus by ondansetron. Schwörer H; Ramadori G Lancet; 1993 May; 341(8855):1277. PubMed ID: 8098410 [No Abstract] [Full Text] [Related]
53. Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions. Jones EA; Neuberger J; Bergasa NV QJM; 2002 Aug; 95(8):547-52. PubMed ID: 12145394 [TBL] [Abstract][Full Text] [Related]
54. Plasma exchange for the management of refractory pruritus of cholestasis: A report of three cases and review of literature. Chkheidze R; Joseph R; Burner J; Matevosyan K J Clin Apher; 2018 Jun; 33(3):412-418. PubMed ID: 28792089 [TBL] [Abstract][Full Text] [Related]